Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1

K-Number: K002556 · 2000-10-31

ApplicantPharmacia & Upjohn Co.
Decision Date2000-10-31
Product CodeMSS
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1 is the device name listed in this FDA 510(k) record. The listed applicant is Pharmacia & Upjohn Co.. It received FDA 510(k) clearance on 2000-10-31 under 510(k) number K002556. The device is classified under product code MSS. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1?

CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1 is a medical device that received FDA 510(k) clearance on 2000-10-31. The listed applicant is Pharmacia & Upjohn Co.. The 510(k) number is K002556.

When did CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1 receive FDA 510(k) clearance?

CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1 received FDA 510(k) clearance on 2000-10-31, under 510(k) number K002556.

Who is the listed applicant for CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1?

The FDA 510(k) record lists Pharmacia & Upjohn Co. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1?

The FDA product code for CEEON EASYSERT INTRAOCULAR LENS INJECTOR, MODEL IMP-1 is MSS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pharmacia & Upjohn Co. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K003414VARELISA TG (THYROGLOBULIN) ANTIBODIES,K000312VARELISA SM ANTIBODIESK000132ALLERGEN IMMUNOCAP, MODELS C74, E89, EX2, EX70, EX71, EX73, FX8, FX9, FX10, FX16, FX73, I72, I75, I76, K71, K73, K81, K8K993585VARELISA TPO ANTIBODIES, MODEL 12348/12396K993388ALLERGEN IMMUNDOCAP MODELC5, C6, C73, E201, E213, F50, F51,F54, F55, F56, F57, F58, F59, F60, F61, F205, F213, F218, FK993589VARELISA RNP ANTIBODIES

View all 18 devices →

Related Devices (Code: MSS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261174RxSight® Insertion DeviceRxsight, Inc.K252540ACCUJECT Injector Set 2.1-1P (LP604590)Medicel AGK242389EyeGility™ Inserter for Preloaded enVista IOLsBausch & Lomb, IncorporatedK231106Accuject Refra Injector AR2900Medicel AGK231838RxSight® Insertion Device (63002)Rxsight, Inc.K231466RxSight Insertion DeviceRxsight, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑